These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12216276)

  • 21. Detergent-lentiviral combination gives gene therapy hope for cystic fibrosis.
    Bradbury J
    Lancet; 2002 Oct; 360(9342):1306. PubMed ID: 12414210
    [No Abstract]   [Full Text] [Related]  

  • 22. Advances in cystic fibrosis therapies.
    Rowe SM; Clancy JP
    Curr Opin Pediatr; 2006 Dec; 18(6):604-13. PubMed ID: 17099358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cystic fibrosis and gene therapy].
    Setoguchi Y; Yokoyama T
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():607-16. PubMed ID: 16416861
    [No Abstract]   [Full Text] [Related]  

  • 24. Widespread airway distribution and short-term phenotypic correction of cystic fibrosis pigs following aerosol delivery of piggyBac/adenovirus.
    Cooney AL; Singh BK; Loza LM; Thornell IM; Hippee CE; Powers LS; Ostedgaard LS; Meyerholz DK; Wohlford-Lenane C; Stoltz DA; B McCray P; Sinn PL
    Nucleic Acids Res; 2018 Oct; 46(18):9591-9600. PubMed ID: 30165523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adeno-associated virus vectors for gene therapy of cystic fibrosis.
    Flotte TR; Carter BJ
    Methods Enzymol; 1998; 292():717-32. PubMed ID: 9711594
    [No Abstract]   [Full Text] [Related]  

  • 26. Retrovirus-mediated gene therapy to fetal lung.
    Pitt BR; Robbins PD
    Mol Hum Reprod; 1996 Jul; 2(7):467-9. PubMed ID: 9239652
    [No Abstract]   [Full Text] [Related]  

  • 27. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
    Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
    Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Old hopes and new horizons for treating cystic fibrosis.
    Featherstone C
    Lancet; 1996 Jun; 347(9014):1544. PubMed ID: 8684112
    [No Abstract]   [Full Text] [Related]  

  • 29. [New advances in the management and treatment of cystic fibrosis].
    Mihălţan F
    Pneumologia; 2014; 63(1):21-5. PubMed ID: 24800591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspectives on gene therapy for cystic fibrosis airway disease.
    Bigger B; Coutelle C
    BioDrugs; 2001; 15(9):615-34. PubMed ID: 11580305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status and future prospects for the treatment of lung disease in cystic fibrosis by gene therapy.
    Porteous DJ
    Pulm Pharmacol; 1994 Jun; 7(3):153-7. PubMed ID: 7530071
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel, mechanism-based therapies for cystic fibrosis.
    Rubenstein RC
    Curr Opin Pediatr; 2005 Jun; 17(3):385-92. PubMed ID: 15891431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retroviral approaches to gene therapy of cystic fibrosis.
    Johnson LG
    Ann N Y Acad Sci; 2001 Dec; 953():43-52. PubMed ID: 11795422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in cystic fibrosis.
    Doull IJ
    Arch Dis Child; 2001 Jul; 85(1):62-6. PubMed ID: 11420207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy: the case for cystic fibrosis.
    Alton EW; Geddes D
    J R Soc Med; 1997; 90 Suppl 31(Suppl 31):43-6. PubMed ID: 9204011
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
    Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
    Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
    [No Abstract]   [Full Text] [Related]  

  • 38. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee T; Southern KW
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005599. PubMed ID: 17443603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic fibrosis. Difficulties of gene therapy.
    McCray PB
    Lancet; 2001 Dec; 358 Suppl():S19. PubMed ID: 11784568
    [No Abstract]   [Full Text] [Related]  

  • 40. [Gene therapy: development of adenovirus vectors].
    Siegfried W
    Pneumologie; 1996 Dec; 50 Suppl 3():860-4. PubMed ID: 9157443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.